Top Markets
#1 MowCat MowCat +48.88%
#2 Bermuda Shorts Bermuda Shorts +25.27%
#3 Velvet Velvet +25.14%
#4 Derive Derive +21.09%
#5 Audiera Audiera +20.34%
#6 Biconomy Biconomy +18.91%
#7 aPriori aPriori +18.15%
#8 Quack AI Quack AI +17.54%
#9 Geodnet Geodnet +12.27%
#10 Perle Perle +10.44%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
Firebrick Pharma Limited Firebrick Pharma Limited

Firebrick Pharma Limited

FRE
Rank in Stocks #35032
Firebrick Pharma Limited, an enterprise established in 2012 and headquartered... Firebrick Pharma Limited, an enterprise established in 2012 and headquartered in Melbourne, Australia, is dedicated to the research, development, and market launch of Nasodine, a nasal spray treatment for the common cold, exclusively for the Australian market.
Share Price
$0.01904269
Last synced: 2026-08-14
Market Cap
$4.55M
Change (1 day)
0.00%
Change (1 year)
-63.41%
Country
AU
Trade Firebrick Pharma Limited (FRE)

Category

Healthcare
P/B ratio for Firebrick Pharma Limited (FRE)
P/B ratio as of 2026 TTM: 0
According to Firebrick Pharma Limited latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Firebrick Pharma Limited from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 31.0864 -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7.4766 -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 -74.4354 -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 8.4776 -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 8.008 -
US